Published in N Engl J Med on December 28, 1989
The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study Group. J Clin Epidemiol (1996) 2.56
Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health (1993) 2.16
Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004). Clin Infect Dis (2011) 1.83
Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpesviruses. Am J Pathol (1999) 1.78
Early immunological predictors of neurodevelopmental outcomes in HIV-infected children. Clin Infect Dis (2009) 1.68
Simian immunodeficiency virus infection in neonatal macaques. J Virol (2003) 1.54
Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol (1998) 1.50
Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. J Clin Invest (1994) 1.41
Modeling the impact of breast-feeding by HIV-infected women on child survival. Am J Public Health (1990) 1.40
Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol (1995) 1.39
Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J Virol (1995) 1.31
Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol (1998) 1.30
Vertically transmitted HIV infection in the British Isles. BMJ (1993) 1.29
Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother (1995) 1.18
Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol (2000) 1.09
Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1995) 1.08
Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol (1992) 1.08
Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles. Arch Dis Child (1994) 1.07
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child. J Virol (2002) 1.06
Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers. Clin Diagn Lab Immunol (2004) 0.97
Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection. MBio (2015) 0.97
HIV-1 infection and perinatal mortality in Zimbabwe. Arch Dis Child (1992) 0.96
Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus. Clin Diagn Lab Immunol (1996) 0.95
Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94
Oral manifestation of HIV/AIDS infections in paediatric Nigerian patients. Niger Med J (2012) 0.94
Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice. J Virol (2007) 0.93
Evaluation and treatment of the human immunodeficiency virus-1-exposed infant. Paediatr Child Health (2004) 0.93
Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children. Clin Exp Immunol (1993) 0.91
Congenital virus infections. BMJ (1990) 0.90
Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial. Arch Dis Child (2001) 0.90
Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus. Am J Pathol (1998) 0.89
Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine. BMC Pediatr (2010) 0.88
Prevalence of Human Immunodeficiency Virus Transmission among Transfused Children with Sickle Cell Anemia in Enugu Nigeria. Ann Med Health Sci Res (2012) 0.88
Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection. Pediatr Infect Dis J (2012) 0.87
HIV-1 infection in a cohort of haemophilic patients. Arch Dis Child (1990) 0.86
Detection of human immunodeficiency virus type 1 RNA in plasma samples from high-risk pediatric patients by using the self-sustained sequence replication reaction. J Clin Microbiol (1992) 0.81
HIV infection in children. BMJ (1991) 0.81
Pediatric human immunodeficiency virus infection. Clin Microbiol Rev (1996) 0.81
Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection. Clin Diagn Lab Immunol (1999) 0.81
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. Antimicrob Agents Chemother (1999) 0.80
Sexually transmitted diseases in children: HIV infection. Genitourin Med (1992) 0.79
Pulmonary pathology in AIDS: atypical Pneumocystis carinii infection and lymphoid interstitial pneumonia. Thorax (1994) 0.79
Development of a culturally appropriate health-related quality of life measure for human immunodeficiency virus-infected children in Thailand. J Paediatr Child Health (2010) 0.78
Zidovudine therapy in HIV infection: which patients should be treated and when. Br J Clin Pharmacol (1995) 0.76
The impact of HIV infection on childhood pneumonia: comparison between developed and developing regions. Malawi Med J (2002) 0.75
Diagnosis and treatment of the acquired immunodeficiency syndrome in children. West J Med (1990) 0.75
Pediatric infections. Can J Infect Dis (1992) 0.75
Pneumocystis prophylaxis for all, some, or no HIV-infected infants less than one year of age: A decision analysis approach. Can J Infect Dis (1993) 0.75
Prognostic value of immunological data, in vitro antibody production, and virus culture in vertical infection with HIV-1. Arch Dis Child (1995) 0.75
HIV infection in children. Arch Dis Child (1992) 0.75
Constraints and prospects in the management of pediatric HIV/AIDS. J Natl Med Assoc (2006) 0.75
Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath. Thorax (1994) 0.75
HIV infection and haemophilia. Arch Dis Child (1991) 0.75
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science (1986) 7.81
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science (1992) 7.44
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med (1999) 6.13
Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus. J Virol (1973) 5.28
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Extensive variation of human immunodeficiency virus type-1 in vivo. Nature (1988) 5.02
A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc Natl Acad Sci U S A (1973) 4.55
Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA (2000) 4.49
Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. J Clin Epidemiol (1996) 4.26
Probabilities will help us plan for climate change. Nature (2001) 4.04
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci (2001) 4.02
Harvey sarcoma virus: a second murine type C sarcoma virus with rat genetic information. J Virol (1974) 3.92
Friend strain of spleen focus-forming virus: a recombinant between mouse type C ecotropic viral sequences and sequences related to xenotropic virus. J Virol (1977) 3.70
Separation of sarcoma virus-specific and leukemia virus-specific genetic sequences of Moloney sarcoma virus. Proc Natl Acad Sci U S A (1975) 3.28
Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses. J Immunol (1972) 3.23
Stratified randomization for clinical trials. J Clin Epidemiol (1999) 3.16
Physical assay and growth cycle studies of a defective adeno-satellite virus. J Virol (1967) 3.15
Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide. Proc Natl Acad Sci U S A (1972) 2.90
Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem (1981) 2.77
Immunological characterization of primate C-type virus reverse transcriptases. Nat New Biol (1972) 2.73
Emergency nurses facing more violence. Nurs N Z (2001) 2.68
Type C particle-positive and type C particle-negative rat cell lines: characterization of the coding capacity of endogenous sarcoma virus-specific RNA. J Virol (1976) 2.67
Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses. J Virol (1972) 2.65
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57
Isolation of a fibroblast nonproducer cell line containing the Friend strain of the spleen focus-forming virus. Virology (1977) 2.47
Deletion mapping of moloney type C virus: polypeptide and nucleic acid expression in different transforming virus isolates. J Virol (1976) 2.39
RNA dependent DNA polymerase activity in mammalian cells. Nature (1971) 2.37
Dexamethasone stimulation of murine mammary tumor virus expression: a tissue culture source of virus. Science (1974) 2.34
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Steroid induction of mouse mammary tumor virus: effect upon synthesis and degradation of viral RNA. J Virol (1977) 2.26
On reaching the tunnel at the end of the light. J Clin Epidemiol (1997) 2.20
Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13
Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid. J Virol (1967) 2.10
Acquired immunodeficiency syndrome in infants. N Engl J Med (1984) 2.09
Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut (2001) 2.08
A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med (1984) 2.06
Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA (1985) 2.02
Factors associated with HIV prevalence in a pre-partum cohort of Zambian women. Int J STD AIDS (2006) 2.02
Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol (2006) 2.02
Adjusted survival curve estimation using covariates. J Chronic Dis (1982) 1.98
Levels of rat cellular RNA homologous to either Kirsten sarcoma virus or rat type-C virus in cell lines derived from Osborne-Mendel rats. J Virol (1974) 1.86
Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses. Proc Natl Acad Sci U S A (1971) 1.86
Complications occurring in the postanesthesia care unit: a survey. Anesth Analg (1992) 1.85
Mammary tumor virus induction by glucocorticoids. Characterization of specific transcriptional regulation. J Biol Chem (1975) 1.76
Biochemical and physiological mechanisms in glucocorticoid hormone induction of mouse mammary tumor virus. Virology (1976) 1.74
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Mechanism of DNA strand nicking at apurinic/apyrimidinic sites by Escherichia coli [formamidopyrimidine]DNA glycosylase. Biochem J (1989) 1.72
The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64
A novel approach to insertion of the Montgomery T-tube. Anaesthesia (1994) 1.62
Partial transcription of murine type C viral genomes in BALB c cell lines. J Virol (1973) 1.61
Reverse transcriptases of primate viruses as immunological markers. Science (1972) 1.61
An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol (1982) 1.60
Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics (1996) 1.60
Genetics and child psychiatry: II Empirical research findings. J Child Psychol Psychiatry (1999) 1.59
Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet (1981) 1.58
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol (1984) 1.55
Murine leukaemia virus group-specific antigen in the C-type virus-containing human cell line, ESP-1. Nature (1971) 1.53
Immunochemical characterization of two major polypeptides from murine mammary tumor virus. J Virol (1974) 1.52
A case-control study of cancer of the endometrium. Am J Epidemiol (1982) 1.50
Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. Arch Pediatr Adolesc Med (1997) 1.49
Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med (1986) 1.49
A biochemical and genetic analysis of mammalian RNA-containing sarcoma viruses. Cold Spring Harb Symp Quant Biol (1975) 1.49
'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo. AIDS (2001) 1.48
Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus. J Pediatr (1996) 1.47
When does palliative care begin? A needs assessment of cancer patients with recurrent disease. J Palliat Care (1995) 1.46
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest (1987) 1.43
Quantitative analysis of the rescue of RNA sequences by mammalian type C viruses. J Virol (1975) 1.42
Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer (1973) 1.42
RNA dependent DNA polymerase in primate syncytium-forming (foamy) viruses. Nature (1971) 1.42
Is the pressure rate quotient a predictor or indicator of myocardial ischemia as measured by ST-segment changes in patients undergoing coronary artery bypass surgery? Anesthesiology (1991) 1.41
Central nervous system tuberculosis in children. Pediatr Neurol (1991) 1.41
Double gloving can be a hazard in theatre. Nurs N Z (2001) 1.39
ACC stops payments to rest-home nurses. Nurs N Z (2000) 1.39
Religious aged care homes struggling. Nurs N Z (2002) 1.38
Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr (1994) 1.38
Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Am J Pathol (1998) 1.37
Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol (1989) 1.36
Murine mammary tumor cell clones with varying degrees of virus expression. Virology (1973) 1.35
Glucocorticoid-receptor interaction and induction of murine mammary tumor virus. J Biol Chem (1975) 1.34
In vitro translation of Harvey murine sarcoma virus RNA. J Virol (1977) 1.32
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. Am J Obstet Gynecol (1993) 1.31
Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics (2000) 1.30
Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med (1987) 1.30
Enzyme and hemoglobin retention in human erythrocyte stroma. Biochim Biophys Acta (1965) 1.29
Reversible inactivation of the deoxyribonucleic acid polymerase of Rauscher leukemia virus. J Virol (1972) 1.29
High frequency variation in mammary tumor virus expression in cell culture. Cell (1976) 1.29
Sample size requirements for comparing time-to-failure among k treatment groups. J Chronic Dis (1982) 1.26
Increased rate of cytomegalovirus infection among day care center workers. Pediatr Infect Dis J (1990) 1.26
Application of a human tumor colony-forming assay to new drug screening. Cancer Res (1985) 1.26
Isolation of a primate type-C virus from a lymphomatous baboon. Int J Cancer (1974) 1.25
Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology (1993) 1.25
An epidemiologic study of lifting and twisting on the job and risk for acute prolapsed lumbar intervertebral disc. J Orthop Res (1984) 1.24
Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis (1981) 1.24
The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke (2000) 1.24
A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr (1991) 1.23
Intrauterine herpes simplex virus infections. J Pediatr (1987) 1.22